Adverum Biotechnologies, Inc. · Redwood City, CA, US
· Posted 2026-05-28
· 3-5 years
Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Lever
AnalystIIIReviewerreviewadverumqualitydocumentationanalytical
Adverum Biotechnologies, Inc. · Redwood City, CA, US
· Posted 2026-04-24
· 8+ years
Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Lever
ScientistDownstreamProcessDevelopmentadverumgenesupporttherapy
Adverum Biotechnologies, Inc. · Redwood City, CA, US
· Posted 2026-02-17
· 13+ years
Adverum Biotechnologies, Inc., a wholly owned subsidiary of Eli Lilly and Company is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leve
DirectorSystemsqualityabilityadverumregulatorycross-functionalinternal
Adverum Biotechnologies, Inc. · Redwood City, CA, US
· Posted 2020-10-29
Adverum is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the capabilities of its proprietary intravitreal platform, Adverum is developing d
adverumocularagenciesgenetherapystandardcarediseases